End Prescription Drug Ads Now Act bans drug manufacturers from using direct-to-consumer advertising to promote their products.
The End Prescription Drug Ads Now Act amends the Federal Food, Drug, and Cosmetic Act to prohibit drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products. This prohibition applies to any drug approved under the Federal Food, Drug, and Cosmetic Act or licensed under the Public Health Service Act, regardless of when the drug was approved or licensed. The amendment takes effect 30 days after the enactment of this Act.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.